Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variants of m6A modification genes are associated with survival of HBV-related hepatocellular carcinoma.

Journal of cellular and molecular medicine - 1 Aug 2024

Liu Shuyan, Li Jianxu, Qiu Moqin, Liu Yingchun, Wen Qiuping, Lin Qiuling, Jiang Yanji, Zhou Zihan, Liang Xiumei, Wei Xiaoxia, Yu Hongping, Chen Peiqin

Abstract excerpt

N6-methyladenosine (m6A) is a dynamic and reversible modification process involving in a series of important biological and pathophysiological processes, including the progression of cancers. Herein, we aimed to assess the relationships of genetic variants in m6A modification genes with the survival of hepatitis B virus -related hepatocellular carcinoma (HBV-HCC). We performed a two-stage survival analysis to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B

Share to Hepatitis B virus

Share to Liver Neoplasms

Share to Methyltransferases

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 39163514
DOI: 10.1111/jcmm.18517
PMCID: PMC11335057

Genes

METTL3
ADARB1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variants of m6A modification genes are associated with survival of HBV-related hepatocellular carcinoma.PMID 39163514Read ↗

m6A-SNPs identified by integrating genomic data are associated with the occurrence and prognosis of HCC.Semantic proximity Read ↗

Development of N6-methyladenosine Related Signature as New Biomarker for Prognosis of Hepatocellular Carcinoma and Correlates with Sorafenib and anti-PD-1 Immunotherapy Treatment ResponseSemantic proximity Read ↗

Genetic variants in m5C modification genes are associated with survival of patients with HBV-related hepatocellular carcinoma.Semantic proximity Read ↗

Construction of a Prognostic m6A-related lncRNA Signature to Predict Immunotherapy and Chemotherapy Response in Hepatocellular CarcinomaSemantic proximity Read ↗

The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinomaSemantic proximity Read ↗

The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinomaSemantic proximity Read ↗

M 6A-related genes characterization in hepatocellular cancer identifies prognostic relevant gene signaturesSemantic proximity Read ↗

Significance of m 6A Methyltransferase‑Related lncRNAs in the Prognosis and Immunotherapy of Hepatocellular CarcinomaSemantic proximity Read ↗

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinomaSemantic proximity Read ↗

Comprehensive Analysis of m6A Modification in Immune Infiltration, Metabolism and Drug Resistance in Hepatocellular CarcinomaSemantic proximity Read ↗

m6A RNA Methylation Regulators de fine tumor microenvironment and predict prognosis in hepatocellular carcinomaSemantic proximity Read ↗

Crosstalk between 5-methylcytosine and N6-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.